330 related articles for article (PubMed ID: 29342970)
1. The Possible Importance of β3 Integrins for Leukemogenesis and Chemoresistance in Acute Myeloid Leukemia.
Johansen S; Brenner AK; Bartaula-Brevik S; Reikvam H; Bruserud Ø
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29342970
[TBL] [Abstract][Full Text] [Related]
2. Role of lipid raft components and actin cytoskeleton in fibronectin-binding, surface expression, and de novo synthesis of integrin subunits in PGE2- or 8-Br-cAMP-stimulated mastocytoma P-815 cells.
Okada Y; Nishikawa J; Semma M; Ichikawa A
Biochem Pharmacol; 2014 Apr; 88(3):364-71. PubMed ID: 24518258
[TBL] [Abstract][Full Text] [Related]
3. In Vivo RNAi screening identifies a leukemia-specific dependence on integrin beta 3 signaling.
Miller PG; Al-Shahrour F; Hartwell KA; Chu LP; Järås M; Puram RV; Puissant A; Callahan KP; Ashton J; McConkey ME; Poveromo LP; Cowley GS; Kharas MG; Labelle M; Shterental S; Fujisaki J; Silberstein L; Alexe G; Al-Hajj MA; Shelton CA; Armstrong SA; Root DE; Scadden DT; Hynes RO; Mukherjee S; Stegmaier K; Jordan CT; Ebert BL
Cancer Cell; 2013 Jul; 24(1):45-58. PubMed ID: 23770013
[TBL] [Abstract][Full Text] [Related]
4. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia.
Wang A; Zhong H
Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132
[TBL] [Abstract][Full Text] [Related]
5. Stromal CYR61 Confers Resistance to Mitoxantrone via Spleen Tyrosine Kinase Activation in Human Acute Myeloid Leukaemia.
Long X; Yu Y; Perlaky L; Man TK; Redell MS
Br J Haematol; 2015 Sep; 170(5):704-18. PubMed ID: 25974135
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow fibroblast exposure to the inflammatory cytokines tumor necrosis factor-alpha and interferon-gamma increases adhesion of acute myeloid leukemia cells and alters the adhesive mechanism.
Bendall LJ; Kortlepel K; Gottlieb DJ
Exp Hematol; 1997 Feb; 25(2):132-9. PubMed ID: 9015213
[TBL] [Abstract][Full Text] [Related]
7. Targeting integrins in drug-resistant acute myeloid leukaemia.
Ogana HA; Hurwitz S; Wei N; Lee E; Morris K; Parikh K; Kim YM
Br J Pharmacol; 2024 Jan; 181(2):295-316. PubMed ID: 37258706
[TBL] [Abstract][Full Text] [Related]
8. A naturally occurring extracellular alpha-beta clasp contributes to stabilization of beta3 integrins in a bent, resting conformation.
Vomund AN; Stuhlsatz-Krouper S; Dimitry J; Song Y; Frazier WA
Biochemistry; 2008 Nov; 47(44):11616-24. PubMed ID: 18841997
[TBL] [Abstract][Full Text] [Related]
9. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C
Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165
[TBL] [Abstract][Full Text] [Related]
10. Transient potential receptor melastatin-2 (Trpm2) does not influence murine MLL-AF9-driven AML leukemogenesis or in vitro response to chemotherapy.
Haladyna JN; Pastuer T; Riedel SS; Perraud AL; Bernt KM
Exp Hematol; 2016 Jul; 44(7):596-602.e3. PubMed ID: 27033163
[TBL] [Abstract][Full Text] [Related]
11. Human acute myeloid leukaemia cells express adhesion proteins and bind to bone marrow fibroblast monolayers and extracellular matrix proteins.
Kortlepel K; Bendall LJ; Gottlieb DJ
Leukemia; 1993 Aug; 7(8):1174-9. PubMed ID: 8350618
[TBL] [Abstract][Full Text] [Related]
12. Human acute myeloid leukemia cells bind to bone marrow stroma via a combination of beta-1 and beta-2 integrin mechanisms.
Bendall LJ; Kortlepel K; Gottlieb DJ
Blood; 1993 Nov; 82(10):3125-32. PubMed ID: 7693037
[TBL] [Abstract][Full Text] [Related]
13. Secreted β3-integrin enhances natural killer cell activity against acute myeloid leukemia cells.
Skaik Y; Vahlsing S; Goudeva L; Eiz-Vesper B; Battermann A; Blasczyk R; Figueiredo C
PLoS One; 2014; 9(2):e98936. PubMed ID: 24919191
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of Flt3 is a passive event in Hoxa9/Meis1-induced acute myeloid leukemia in mice.
Staffas A; Arabanian LS; Wei SY; Jansson A; Ståhlman S; Johansson P; Fogelstrand L; Cammenga J; Kuchenbauer F; Palmqvist L
Oncogene; 2017 Mar; 36(11):1516-1524. PubMed ID: 27617578
[TBL] [Abstract][Full Text] [Related]
15. β2 integrin-derived signals induce cell survival and proliferation of AML blasts by activating a Syk/STAT signaling axis.
Oellerich T; Oellerich MF; Engelke M; Münch S; Mohr S; Nimz M; Hsiao HH; Corso J; Zhang J; Bohnenberger H; Berg T; Rieger MA; Wienands J; Bug G; Brandts C; Urlaub H; Serve H
Blood; 2013 May; 121(19):3889-99, S1-66. PubMed ID: 23509157
[TBL] [Abstract][Full Text] [Related]
16. SHP1 regulates a STAT6-ITGB3 axis in FLT3ITD-positive AML cells.
Reich D; Kresinsky A; Müller JP; Bauer R; Kallenbach J; Schnoeder TM; Heidel FH; Fässler R; Mann M; Böhmer FD; Jayavelu AK
Leukemia; 2020 May; 34(5):1444-1449. PubMed ID: 31836852
[No Abstract] [Full Text] [Related]
17. Midostaurin/PKC412 for the treatment of newly diagnosed FLT3 mutation-positive acute myeloid leukemia.
Luskin MR; DeAngelo DJ
Expert Rev Hematol; 2017 Dec; 10(12):1033-1045. PubMed ID: 29069942
[TBL] [Abstract][Full Text] [Related]
18. The structure and function of platelet integrins.
Bennett JS; Berger BW; Billings PC
J Thromb Haemost; 2009 Jul; 7 Suppl 1():200-5. PubMed ID: 19630800
[TBL] [Abstract][Full Text] [Related]
19. Transformation of human CD34+ hematopoietic progenitor cells with DEK-NUP214 induces AML in an immunocompromised mouse model.
Qin H; Malek S; Cowell JK; Ren M
Oncogene; 2016 Oct; 35(43):5686-5691. PubMed ID: 27065320
[TBL] [Abstract][Full Text] [Related]
20. Splenic tyrosine kinase (SYK) inhibitors and their possible use in acute myeloid leukemia.
Bartaula-Brevik S; Lindstad Brattås MK; Tvedt THA; Reikvam H; Bruserud Ø
Expert Opin Investig Drugs; 2018 Apr; 27(4):377-387. PubMed ID: 29611449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
